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tissues  and  elude  anticancer  treatments.  It  is  therefore  important  to  understand  the 
mechanisms underlying migration process, in order to aid the development of therapies 
aimed at blocking the dissemination of cancer cells. 




Results.  Quantitative  (computer-assisted  colour  camera  equipped-light  microscopy) 
and qualitative analysis  (SEM)  indicated  that  the most aggressive  tumour cells adopt 
an “individual” behaviour. The analysis of intracellular signalling demonstrated that the 
highest  invasive  potential was  associated with  the  activation  of AKT, ERK, FAK and 
ERM proteins.  The  “individual”  behaviour was positively  related  to  the  expression of 
VLA-2 and inversely related with the E-cadherin expression.



















hesions are  retained  [5-8]. The process  that underlies 
both  types of migration  is  the  remodelling of  the  cell 
cytoskeleton that couples with cell surface receptors in-
teracting with  surrounding  tissue  structures;  thus,  the 








By  shifting  between  different  migration  strategies, 
migrating  cells  can  adapt  to  environmental  changes 
and  matrix  stiffness  to  elude  anticancer  treatments. 














































gap  is measured.  In  the microliter-scale migration as-
says,  selected molecules  are  deposited  on  a  substrate 




examines  migration  of  cells  through  a  porous  insert 
(Transwell™)  in  response  to  specific  attractant.  Cells 
are seeded on the top of the insert and the cells cross-













investigation  of  tumour  cell  migration  and  invasion. 
This combination comprises 2D (Boyden chamber as-
say) and 3D (Modified Boyden chamber assay) in vitro 
assays,  biochemical  tests  and  ultrastructural  investi-












glioblastoma,  human  melanoma  (M14 WT  and M14 













Invasion and motility assays
To analyse the migration and invasion potential of tu-
mour cells, 2D (Boyden chamber assay) and 3D (Modi-









again  and  then  allowed  to  dry.  The  detection  of  cells 
that passed  through  the membrane pores  (migration) 
and  invaded Matrigel™  (invasion) was  obtained  by  a 
computer-assisted colour camera equipped Nikon Op-
tiphot microscope and the percentage of area occupied 
by migrated  cells was  analysed by dedicated  software 
(Optilab  Graftek).  The  image  processing  techniques 













with  a  Cambridge  Stereoscan  360  scanning  electron 
microscope  (Cambridge  Instruments,  Cambridge, 
United Kingdom). 
Western blotting
The  analysis  of  MAPK  phosphorylation  was  per-





30  mM  sodium  pyrophosphate,  5  mM  EDTA,  0.5% 
Nonidet P40, 1% Triton X-100, 50 mM NaF, 0.1 mM 



















molecules  (E-Cadherin,  VLA2,  VLA5,  CD44)  cells 
























were  detached  and  incubated  in  phosphate  buffered 
saline  (PBS)  containing  0.5%  bovine  serum  albumin 
(BSA). Then, cells were incubated for 30 minutes at 4 
°C with specific monoclonal antibody directed against 
surface  antigens.  After  incubating,  the mixtures were 
centrifuged  twice  using  cold  PBS  solution  containing 
0.5% BSA  and  incubated with  fluorescein  isothiocya-
nate  (FITC)-conjugated  secondary  antibodies  for  30 
minutes at 4 °C. Finally, cells washed twice using PBS 
containing 0.5% BSA were immediately analysed. Prop-
idium  iodide  (PI)  was  used  to  recognize  dead  cells. 







filter  while  propidium  iodide  signal  with  a  band-pass 
filter 575 nm. 
RESULTS AND DISCUSSION
Study of the migration and invasion potential 
In  this  study  several  tumour  cell  lines  of  different 
histotypes were employed. In particular, three human 
breast  carcinoma  cell  lines  (MDA-MB-231, MCF-7 





variants  LoVo  ADR)  were  employed.  Drug-resistant 
variants overexpress the multidrug transmembrane P-
glycoprotein, capable of transporting structurally and 
functionally not  related xenobiotics,  thus  responsible 
for the pleiotropic resistance of tumour cells [18]. The 













absence  (migration)  or  in  the  presence  (invasion)  of 
MatrigelTM  film,  was  then  evaluated  (Supplementary 
data 1 and 2 available online at www.iss.it/anna). 
In  our  experimental  conditions  different  migratory 
and invasive potentials were found and the percentage 
of  area  occupied  by  the  tested  tumour  cell  lines  that 
have been listed in a descending order in Table 1.
Human breast cancer MDA-MB-231 cells displayed 
the  highest  capacity  of migrating,  as  showed  by  the 
percentage of occupied area on the lower side of the 
porous  membrane  (50.0%).  This  value  appeared  to 
be  exceptionally  high when  compared with  both  the 
breast  carcinoma  cell  lines MCF-7 WT  and MCF-7 
ADR cells and the other tumour cells of different his-
totypes.  However, MCF-7  ADR  cells  showed  to  be 
faster (2.8%) than their sensitive counterparts MCF-7 
WT  cells  (1.2%).  Also  in  the  presence  of MatrigelTM 
MDA-MB-231 cells displayed the highest potential of 
invasion (58.0%) in comparison with the other tumour 
cells.  Differently  from  their  sensitive  counterparts, 
MCF-7 ADR resistant variants appeared to be stimu-




















when  compared  to  their  drug  sensitive  counterparts. 













Percentage of area occupied by cells migrated on the lower 
side of the filter in the absence (migration) and in the presence 
(invasion) of Matrigel™
Migration (%) Invasion (%)
MDA 50.0 MDA 58.0
C6 22.0 C6 29.2
M14 ADR 17.8 LN229 26.7
LN229 15.0 M14 ADR 22.7
M14 WT 11.3 M14 WT 10.9
MCF-7 ADR   2.8 MCF-7 ADR  4.2
LoVo ADR       2.0 LoVo ADR     3.7
LoVo WT      1.7 LoVo WT       3.3
MCF-7 WT    1.2 MCF-7 WT    0



































cells  it  can  be  identified  a  leader,  called  by  some  au-
thors  “Guerilla  cell”  [23].  These  leader  cells  generate 
the  traction  force  necessary  for  the  migration  of  the 
group through the activity of pseudopodia, pulling be-
hind resting cells.
Among  human  breast  carcinoma  MDA-MB-231, 
MCF-7 WT and MCF-7 ADR cells different migratory 
behaviours were  identified  (Figure 1 a-f). The greatest 
migration potential of  this  tumour appeared to be as-
sociated with an individual behaviour. In fact, MCF-7 
WT  cells  less  active  in  the migration  assay  tended  to 











membrane  (Figure 1 e).  SEM observations  performed 










Scanning electron microscopy observations performed on the 
upper side (a, c, e, g, i, k, m) and on the lower side (b, d, f, h, j, l, 
n) of the filter during the migration process.  The observations 
performed on the upper side provide evidence that MCF-7 
WT (a), LN229 (g) and LoVo ADR (m) cells adopted a “collec-
tive” behaviour, whereas MDA-MB-231(e), C6 (i) and LoVo WT 
(k) cells adopted a “individual” behaviour. MCF-7 ADR (c) cells 
showed a “mixed” behaviour. Cells that adopt an individual 
behaviour tend to separate from the rest of the cell popula-
tion and to pass through the pores individually. In the “collec-
tive” behaviour clusters of cells move closely linked each other. 
In these groups of cells it can be identified a leader (arrows) 
dragging the other cells. These leader cells generate the trac-
tion force necessary for the migration of the group, through 
the activity of pseudopodia, pulling behind resting cells. Ob-
servations performed on the lower side of porous membranes, 
confirmed data obtained by the quantitative analysis. MCF-7 
WT cells samples (b) showed the smallest number of migrated 
cells on the lower side of the filter. In MCF-7 ADR cell samples 
(d) the number of migrated cells increased, while migrated 
MDA-MB-231 cells covered almost the whole area of the lower 
side of the filter (f). In C6 cell sample (j) numerous cells com-
pleted the migration process, in contrast with LN229 cells that 
moved more slowly (h). Finally, LoVo WT samples (l) displayed 
a number of cells lower than their resistant counterpart LoVo 
ADR cells (n).
Enlarged version of the figure 1 is available in Supplementary 
data 3 at www.iss.it/anna
























Even  the glioblastoma cell  lines  showed differences 
in migratory behaviour and also in the case the great-
est migratory potential appeared to be associated with 
an  individual  behaviour. Human  glioblastoma LN229 





individually: on  the  top of  the membrane all  cells ap-














other in small groups (Figures 1 k and m). On the lower 
side of the filter very few if not at all LoVo cells were 
observed (Figure 1 l and n). 
The experiments of invasion were carried out in the 
presence of a MatrigelTM film gelified on the lower side 
of  the membrane.  In  literature  data  two  types  of  be-
haviour  adopted  by  cancer  cells  to  invade  the  extra-
cellular matrix  are  described:  the  “mesenchymal”  and 
the “ameboid” type, depending on the presence or the 
absence of  focused proteolysis,  respectively  [5]. SEM 
observations performed on the upper side of the porous 










Scanning electron microscopy observations performed on the 
upper side (a, c, e, g, i, k, m) and on the lower side (b, d, f, h, 
j, l, n) of the filter during the invasion process in presence of 
Matrigel™. The observations performed on the upper side pro-
vide evidence of “individual” or “collective” behaviour adopted 
by tumour cells. In the presence of a film of MatrigelTM, MCF-7 
WT (a), LoVo WT (k) and LoVo ADR (m) cells adopted a “collec-
tive” behaviour, whereas MDA-MB-231 (e), LN229 (g), and C6 
(i) cells adopted an “individual” behaviour. MCF-7 ADR (c) cells 
showed a “mixed” behaviour. The observations on the lower 
side provide information on the type of tumour cell-extracellu-
lar matrix interactions during the invasion process. MCF-7 WT 
(b), MCF-7 ADR (d), MDA-MB-231 (f) cells adopted a “mesen-
chymal” behaviour whereas, C6) (j), LoVo WT (l) and LoVo ADR 
(n) adopted an “amoeboid-like” behaviour. Cells that adopt a 
“mesenchymal” behaviour showed an intense proteolytic ac-
tivity focused around invadopodia. Focused proteolysis was 
due to proteases strongly concentrated near the binding sites 
between integrins and extracellular matrix. Cells that adopt an 
“amoeboid” behaviour penetrated the fibers of MatrigelTM with-
out degrading it, but infiltrating and invading the extracellular 
matrix. However, there are cells that show a “mixed” behaviour 
(LN229, h): while in some areas matrix degradation was ob-
served, suggesting that cells recurred to an invasion of mes-
enchymal type, in other areas cells appear to infiltrate through 
the mesh of the matrix in “ameboid-like” manner. 
Enlarged version of the figure 2 is available in Supplementary 
data 4 at www.iss.it/anna 







































Human LN229 glioblastoma cells (Figure 2 g and h) 
where  strongly  stimulated  by  the  presence  of  the  ex-
tracellular matrix  and  changed  the  “collective”  in  “in-
dividual” behaviour  in  the  invasion process,  similar as 
murine C6 cells (Figures 2 i and j). Both human (Figure 
2 h) and murine cells (Figure 2 j) penetrated the fibers of 
MatrigelTM apparently without degrading it. In fact, the 













Intracellular signalling underlying migration 
Functional  and  ultrastructural  observations  were 
associated  to  the  analysis  of  intracellular  signalling 





der  migration  in  the  invasion  chambers.  The  kinases 
examined were  p-ERK  1/2  (extracellular-regulated  ki-
nase 1/2), p-PKB (protein kinase B, also named AKT), 
p-FAK (focal adhesion kinase), and p-ERM (ezrina, ra-
dixina, myosin). MAP  kinases  play  an  important  role 
in  various  physiological  processes  such  as  cell  prolif-
eration, differentiation,  inflammation and  response  to 
stress [25]. Evidence showed that MAPKs are essential 
for cell migration and their role relates to the actin as-












migration  through  several  cellular  pathways:  influenc-









stimulated  cells  to  evaluate  the  AKT/PKB  activation. 
Literature data showed the involvement AKT pathway, 
in cell proliferation and metastasis [33]. Arboleda and 








By  analysing  the  results  in  their  complexity  a  posi-






Expression of adhesion molecules 
Flow  cytometry  analysis  allowed  us  to  evaluate  the 
expression of adhesion molecules involved in the met-
astatic  process  such  as E-cadherin, VLA2, VLA5 and 
CD44 [35-40] in the different tumour cell lines.
E-cadherin  is  an  adhesion  molecule  belonging  to 
the  superfamily  of  cadherins.  In  epithelial  tumors  the 
progressive  loss  of E-cadherin  expression  is  correlated 
with  an  increased  aggressiveness  [41].  The  expression 
of this trasmembrane receptor, in fact, provides to both 
the stability of cell-cell junctions and the recruitment of 
β-catenin.  However,  gene  coding  for  E-cadherin  may 









E-cadherin  expression  in  the  cell  lines  with  the  high-
est  migratory  and  invasive  potential,  MDA-MB-231, 
LN229, M14 WT, and M14 ADR cells. On  the other 





mour  aggressiveness  widely  reported  in  the  literature 
























[35,  42]  and  validates  migration  and  invasion  assays 






erature  data  correlate  the  expression  of  these  mol-
ecules with  a more  invasive  and metastatic potential 
[40]. The results obtained showed that MDA-MB-231 
cells  express  the  highest  level  of  the  tested  proteins 
(Figure 3 b, Supplementary data 5 and 6 available on-






that  MDA-MB-231  cells  were  characterized  by  the 
highest  invasive  potential  and  highest  expression  of 
this integrin among the cell lines tested. Also the other 
tumour cells expressed on their membrane VLA2 in-
tegrin but  at  a  lower  level  then MDA-MB-231 cells. 
When the VLA5 expression was examined the human 
melanoma resistant M14 ADR cells, which belong to 










expressed  in  the  resistant  human  adenocarcinoma 
cells and human glioblastoma. It is interesting to note 
that  the CD44  expression  in  drug  resistant  cell  lines 
(MCF-7 ADR, LoVo ADR and M14 ADR cells) was 
higher  than  in  the  relative  sensitive counterparts. The 
VLA2 F4 VLA5 E-cadherin
b
a
MDA-MB-231 M14 ADR M14 WT LOVO ADR
0
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(a) Western blotting analysis of MAP kinase (p-ERK 1/2, p-AKT, p-FAK) activation under the migratory stimulus*. Cells with highest 
migration and invasion potential generally displayed, under migratory stimulus, the highest number of activated molecular path-
ways. (b) Flow cytometry analysis of the adhesion molecule expression. The analysed molecules were E-cadherin, VLA2, VLA5 and 
CD44. Values in ordinate are expressed in arbitrary units and represents positive sample/negative control ratio.












































cells  invade  tissue either  individually  as  single  cells  in 
elongated,  mesenchymal  or  rounded,  amoeboid-like 







chemical  tests  and  ultrastructural  investigations  by 
SEM proved to be particularly suitable for the investi-
gation of tumour cell migration and invasion. The high 
resolution  imaging  by  SEM highlighted  the  interrela-














tageous behaviour  (collective vs  individual) as  showed 
by  human  glioblastoma  cells.  In  addition,  the  results 
obtained  in  this  study confirm  that  the acquisition of 
the multidrugresistant (MDR) phenotype increases the 
invasive potential of tumour cells by the involvement of 
MDR markers  (P-glycoprotein)  and ERM proteins  in 
the MAPK intracellular signalling. 
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